0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bifidobacterium Longum Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-3W1260
Home | Market Reports | Health| Nutrition| Vitamins & Supplements
Global Bifidobacterium Longum Market Insights and Forecast to 2028
BUY CHAPTERS

Global Bifidobacterium Longum Market Insights, Forecast to 2030

Code: QYRE-Auto-3W1260
Report
December 2024
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Bifidobacterium Longum Market

Bifidobacterium longum is a species of small pathogenic bacteria, which naturally occurs in gastrointestinal tracts of human and other animals. The bacterium is added to different types of foods, beverages, and dietary supplements as a probiotic, as it provides many health benefits such as improved digestion and bowel movements.
The global Bifidobacterium Longum market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Bifidobacterium Longum is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Bifidobacterium Longum is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Bifidobacterium Longum is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Bifidobacterium Longum include ATCC Inc, BioGaia AB, Mystic Pharmaceuticals Inc, Hanson Ltd, Biofodan A/S, BioCare Copenhagen ApS, Danisco A/S, Danone SA and Deerland Enzymes Inc., etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Bifidobacterium Longum, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Bifidobacterium Longum, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Bifidobacterium Longum, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Bifidobacterium Longum sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Bifidobacterium Longum market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Bifidobacterium Longum sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Bifidobacterium Longum Market Report

Report Metric Details
Report Name Bifidobacterium Longum Market
Segment by Type
  • 0.2g/Piece
  • 0.25g/Piece
Segment by Application
  • Medicine
  • Others
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Mystic Pharmaceuticals Inc, Hanson Ltd, Biofodan A/S, BioCare Copenhagen ApS, Danisco A/S, Danone SA, Deerland Enzymes Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Bifidobacterium Longum in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Bifidobacterium Longum manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bifidobacterium Longum sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Bifidobacterium Longum Market report?

Ans: The main players in the Bifidobacterium Longum Market are Mystic Pharmaceuticals Inc, Hanson Ltd, Biofodan A/S, BioCare Copenhagen ApS, Danisco A/S, Danone SA, Deerland Enzymes Inc.

What are the Application segmentation covered in the Bifidobacterium Longum Market report?

Ans: The Applications covered in the Bifidobacterium Longum Market report are Medicine, Others

What are the Type segmentation covered in the Bifidobacterium Longum Market report?

Ans: The Types covered in the Bifidobacterium Longum Market report are 0.2g/Piece, 0.25g/Piece

Recommended Reports

Probiotics Supplements

Bifidobacterium Markets

Animal/Feed Probiotics

1 Study Coverage
1.1 Bifidobacterium Longum Product Introduction
1.2 Market by Type
1.2.1 Global Bifidobacterium Longum Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 0.2g/Piece
1.2.3 0.25g/Piece
1.3 Market by Application
1.3.1 Global Bifidobacterium Longum Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Medicine
1.3.3 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Bifidobacterium Longum Sales Estimates and Forecasts 2019-2030
2.2 Global Bifidobacterium Longum Revenue by Region
2.2.1 Global Bifidobacterium Longum Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Bifidobacterium Longum Revenue by Region (2019-2024)
2.2.3 Global Bifidobacterium Longum Revenue by Region (2025-2030)
2.2.4 Global Bifidobacterium Longum Revenue Market Share by Region (2019-2030)
2.3 Global Bifidobacterium Longum Sales Estimates and Forecasts 2019-2030
2.4 Global Bifidobacterium Longum Sales by Region
2.4.1 Global Bifidobacterium Longum Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Bifidobacterium Longum Sales by Region (2019-2024)
2.4.3 Global Bifidobacterium Longum Sales by Region (2025-2030)
2.4.4 Global Bifidobacterium Longum Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Bifidobacterium Longum Sales by Manufacturers
3.1.1 Global Bifidobacterium Longum Sales by Manufacturers (2019-2024)
3.1.2 Global Bifidobacterium Longum Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bifidobacterium Longum in 2023
3.2 Global Bifidobacterium Longum Revenue by Manufacturers
3.2.1 Global Bifidobacterium Longum Revenue by Manufacturers (2019-2024)
3.2.2 Global Bifidobacterium Longum Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Bifidobacterium Longum Revenue in 2023
3.3 Global Key Players of Bifidobacterium Longum, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Bifidobacterium Longum Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Bifidobacterium Longum Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Bifidobacterium Longum, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Bifidobacterium Longum, Product Offered and Application
3.8 Global Key Manufacturers of Bifidobacterium Longum, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Bifidobacterium Longum Sales by Type
4.1.1 Global Bifidobacterium Longum Historical Sales by Type (2019-2024)
4.1.2 Global Bifidobacterium Longum Forecasted Sales by Type (2025-2030)
4.1.3 Global Bifidobacterium Longum Sales Market Share by Type (2019-2030)
4.2 Global Bifidobacterium Longum Revenue by Type
4.2.1 Global Bifidobacterium Longum Historical Revenue by Type (2019-2024)
4.2.2 Global Bifidobacterium Longum Forecasted Revenue by Type (2025-2030)
4.2.3 Global Bifidobacterium Longum Revenue Market Share by Type (2019-2030)
4.3 Global Bifidobacterium Longum Price by Type
4.3.1 Global Bifidobacterium Longum Price by Type (2019-2024)
4.3.2 Global Bifidobacterium Longum Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Bifidobacterium Longum Sales by Application
5.1.1 Global Bifidobacterium Longum Historical Sales by Application (2019-2024)
5.1.2 Global Bifidobacterium Longum Forecasted Sales by Application (2025-2030)
5.1.3 Global Bifidobacterium Longum Sales Market Share by Application (2019-2030)
5.2 Global Bifidobacterium Longum Revenue by Application
5.2.1 Global Bifidobacterium Longum Historical Revenue by Application (2019-2024)
5.2.2 Global Bifidobacterium Longum Forecasted Revenue by Application (2025-2030)
5.2.3 Global Bifidobacterium Longum Revenue Market Share by Application (2019-2030)
5.3 Global Bifidobacterium Longum Price by Application
5.3.1 Global Bifidobacterium Longum Price by Application (2019-2024)
5.3.2 Global Bifidobacterium Longum Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Bifidobacterium Longum Market Size by Type
6.1.1 US & Canada Bifidobacterium Longum Sales by Type (2019-2030)
6.1.2 US & Canada Bifidobacterium Longum Revenue by Type (2019-2030)
6.2 US & Canada Bifidobacterium Longum Market Size by Application
6.2.1 US & Canada Bifidobacterium Longum Sales by Application (2019-2030)
6.2.2 US & Canada Bifidobacterium Longum Revenue by Application (2019-2030)
6.3 US & Canada Bifidobacterium Longum Market Size by Country
6.3.1 US & Canada Bifidobacterium Longum Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Bifidobacterium Longum Sales by Country (2019-2030)
6.3.3 US & Canada Bifidobacterium Longum Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Bifidobacterium Longum Market Size by Type
7.1.1 Europe Bifidobacterium Longum Sales by Type (2019-2030)
7.1.2 Europe Bifidobacterium Longum Revenue by Type (2019-2030)
7.2 Europe Bifidobacterium Longum Market Size by Application
7.2.1 Europe Bifidobacterium Longum Sales by Application (2019-2030)
7.2.2 Europe Bifidobacterium Longum Revenue by Application (2019-2030)
7.3 Europe Bifidobacterium Longum Market Size by Country
7.3.1 Europe Bifidobacterium Longum Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Bifidobacterium Longum Sales by Country (2019-2030)
7.3.3 Europe Bifidobacterium Longum Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Bifidobacterium Longum Market Size
8.1.1 China Bifidobacterium Longum Sales (2019-2030)
8.1.2 China Bifidobacterium Longum Revenue (2019-2030)
8.2 China Bifidobacterium Longum Market Size by Application
8.2.1 China Bifidobacterium Longum Sales by Application (2019-2030)
8.2.2 China Bifidobacterium Longum Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Bifidobacterium Longum Market Size by Type
9.1.1 Asia Bifidobacterium Longum Sales by Type (2019-2030)
9.1.2 Asia Bifidobacterium Longum Revenue by Type (2019-2030)
9.2 Asia Bifidobacterium Longum Market Size by Application
9.2.1 Asia Bifidobacterium Longum Sales by Application (2019-2030)
9.2.2 Asia Bifidobacterium Longum Revenue by Application (2019-2030)
9.3 Asia Bifidobacterium Longum Sales by Region
9.3.1 Asia Bifidobacterium Longum Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Bifidobacterium Longum Revenue by Region (2019-2030)
9.3.3 Asia Bifidobacterium Longum Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Bifidobacterium Longum Market Size by Type
10.1.1 Middle East, Africa and Latin America Bifidobacterium Longum Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Bifidobacterium Longum Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Bifidobacterium Longum Market Size by Application
10.2.1 Middle East, Africa and Latin America Bifidobacterium Longum Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Bifidobacterium Longum Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Bifidobacterium Longum Sales by Country
10.3.1 Middle East, Africa and Latin America Bifidobacterium Longum Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Bifidobacterium Longum Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Bifidobacterium Longum Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 ATCC Inc
11.1.1 ATCC Inc Company Information
11.1.2 ATCC Inc Overview
11.1.3 ATCC Inc Bifidobacterium Longum Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 ATCC Inc Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 ATCC Inc Recent Developments
11.2 BioGaia AB
11.2.1 BioGaia AB Company Information
11.2.2 BioGaia AB Overview
11.2.3 BioGaia AB Bifidobacterium Longum Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 BioGaia AB Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 BioGaia AB Recent Developments
11.3 Mystic Pharmaceuticals Inc
11.3.1 Mystic Pharmaceuticals Inc Company Information
11.3.2 Mystic Pharmaceuticals Inc Overview
11.3.3 Mystic Pharmaceuticals Inc Bifidobacterium Longum Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Mystic Pharmaceuticals Inc Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Mystic Pharmaceuticals Inc Recent Developments
11.4 Hanson Ltd
11.4.1 Hanson Ltd Company Information
11.4.2 Hanson Ltd Overview
11.4.3 Hanson Ltd Bifidobacterium Longum Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Hanson Ltd Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hanson Ltd Recent Developments
11.5 Biofodan A/S
11.5.1 Biofodan A/S Company Information
11.5.2 Biofodan A/S Overview
11.5.3 Biofodan A/S Bifidobacterium Longum Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Biofodan A/S Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Biofodan A/S Recent Developments
11.6 BioCare Copenhagen ApS
11.6.1 BioCare Copenhagen ApS Company Information
11.6.2 BioCare Copenhagen ApS Overview
11.6.3 BioCare Copenhagen ApS Bifidobacterium Longum Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 BioCare Copenhagen ApS Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 BioCare Copenhagen ApS Recent Developments
11.7 Danisco A/S
11.7.1 Danisco A/S Company Information
11.7.2 Danisco A/S Overview
11.7.3 Danisco A/S Bifidobacterium Longum Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Danisco A/S Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Danisco A/S Recent Developments
11.8 Danone SA
11.8.1 Danone SA Company Information
11.8.2 Danone SA Overview
11.8.3 Danone SA Bifidobacterium Longum Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Danone SA Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Danone SA Recent Developments
11.9 Deerland Enzymes Inc.
11.9.1 Deerland Enzymes Inc. Company Information
11.9.2 Deerland Enzymes Inc. Overview
11.9.3 Deerland Enzymes Inc. Bifidobacterium Longum Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Deerland Enzymes Inc. Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Deerland Enzymes Inc. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Bifidobacterium Longum Industry Chain Analysis
12.2 Bifidobacterium Longum Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Bifidobacterium Longum Production Mode & Process
12.4 Bifidobacterium Longum Sales and Marketing
12.4.1 Bifidobacterium Longum Sales Channels
12.4.2 Bifidobacterium Longum Distributors
12.5 Bifidobacterium Longum Customers
13 Market Dynamics
13.1 Bifidobacterium Longum Industry Trends
13.2 Bifidobacterium Longum Market Drivers
13.3 Bifidobacterium Longum Market Challenges
13.4 Bifidobacterium Longum Market Restraints
14 Key Findings in The Global Bifidobacterium Longum Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Bifidobacterium Longum Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of 0.2g/Piece
    Table 3. Major Manufacturers of 0.25g/Piece
    Table 4. Global Bifidobacterium Longum Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Bifidobacterium Longum Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Bifidobacterium Longum Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Bifidobacterium Longum Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Bifidobacterium Longum Revenue Market Share by Region (2019-2024)
    Table 9. Global Bifidobacterium Longum Revenue Market Share by Region (2025-2030)
    Table 10. Global Bifidobacterium Longum Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Bifidobacterium Longum Sales by Region (2019-2024) & (K Pcs)
    Table 12. Global Bifidobacterium Longum Sales by Region (2025-2030) & (K Pcs)
    Table 13. Global Bifidobacterium Longum Sales Market Share by Region (2019-2024)
    Table 14. Global Bifidobacterium Longum Sales Market Share by Region (2025-2030)
    Table 15. Global Bifidobacterium Longum Sales by Manufacturers (2019-2024) & (K Pcs)
    Table 16. Global Bifidobacterium Longum Sales Share by Manufacturers (2019-2024)
    Table 17. Global Bifidobacterium Longum Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Bifidobacterium Longum Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Bifidobacterium Longum, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Bifidobacterium Longum Price by Manufacturers 2019-2024 (USD/Pcs)
    Table 21. Global Bifidobacterium Longum Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Bifidobacterium Longum by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bifidobacterium Longum as of 2023)
    Table 23. Global Key Manufacturers of Bifidobacterium Longum, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Bifidobacterium Longum, Product Offered and Application
    Table 25. Global Key Manufacturers of Bifidobacterium Longum, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Bifidobacterium Longum Sales by Type (2019-2024) & (K Pcs)
    Table 28. Global Bifidobacterium Longum Sales by Type (2025-2030) & (K Pcs)
    Table 29. Global Bifidobacterium Longum Sales Share by Type (2019-2024)
    Table 30. Global Bifidobacterium Longum Sales Share by Type (2025-2030)
    Table 31. Global Bifidobacterium Longum Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Bifidobacterium Longum Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Bifidobacterium Longum Revenue Share by Type (2019-2024)
    Table 34. Global Bifidobacterium Longum Revenue Share by Type (2025-2030)
    Table 35. Bifidobacterium Longum Price by Type (2019-2024) & (USD/Pcs)
    Table 36. Global Bifidobacterium Longum Price Forecast by Type (2025-2030) & (USD/Pcs)
    Table 37. Global Bifidobacterium Longum Sales by Application (2019-2024) & (K Pcs)
    Table 38. Global Bifidobacterium Longum Sales by Application (2025-2030) & (K Pcs)
    Table 39. Global Bifidobacterium Longum Sales Share by Application (2019-2024)
    Table 40. Global Bifidobacterium Longum Sales Share by Application (2025-2030)
    Table 41. Global Bifidobacterium Longum Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Bifidobacterium Longum Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Bifidobacterium Longum Revenue Share by Application (2019-2024)
    Table 44. Global Bifidobacterium Longum Revenue Share by Application (2025-2030)
    Table 45. Bifidobacterium Longum Price by Application (2019-2024) & (USD/Pcs)
    Table 46. Global Bifidobacterium Longum Price Forecast by Application (2025-2030) & (USD/Pcs)
    Table 47. US & Canada Bifidobacterium Longum Sales by Type (2019-2024) & (K Pcs)
    Table 48. US & Canada Bifidobacterium Longum Sales by Type (2025-2030) & (K Pcs)
    Table 49. US & Canada Bifidobacterium Longum Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Bifidobacterium Longum Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Bifidobacterium Longum Sales by Application (2019-2024) & (K Pcs)
    Table 52. US & Canada Bifidobacterium Longum Sales by Application (2025-2030) & (K Pcs)
    Table 53. US & Canada Bifidobacterium Longum Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Bifidobacterium Longum Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Bifidobacterium Longum Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Bifidobacterium Longum Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Bifidobacterium Longum Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Bifidobacterium Longum Sales by Country (2019-2024) & (K Pcs)
    Table 59. US & Canada Bifidobacterium Longum Sales by Country (2025-2030) & (K Pcs)
    Table 60. Europe Bifidobacterium Longum Sales by Type (2019-2024) & (K Pcs)
    Table 61. Europe Bifidobacterium Longum Sales by Type (2025-2030) & (K Pcs)
    Table 62. Europe Bifidobacterium Longum Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Bifidobacterium Longum Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Bifidobacterium Longum Sales by Application (2019-2024) & (K Pcs)
    Table 65. Europe Bifidobacterium Longum Sales by Application (2025-2030) & (K Pcs)
    Table 66. Europe Bifidobacterium Longum Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Bifidobacterium Longum Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Bifidobacterium Longum Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Bifidobacterium Longum Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Bifidobacterium Longum Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Bifidobacterium Longum Sales by Country (2019-2024) & (K Pcs)
    Table 72. Europe Bifidobacterium Longum Sales by Country (2025-2030) & (K Pcs)
    Table 73. China Bifidobacterium Longum Sales by Type (2019-2024) & (K Pcs)
    Table 74. China Bifidobacterium Longum Sales by Type (2025-2030) & (K Pcs)
    Table 75. China Bifidobacterium Longum Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Bifidobacterium Longum Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Bifidobacterium Longum Sales by Application (2019-2024) & (K Pcs)
    Table 78. China Bifidobacterium Longum Sales by Application (2025-2030) & (K Pcs)
    Table 79. China Bifidobacterium Longum Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Bifidobacterium Longum Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Bifidobacterium Longum Sales by Type (2019-2024) & (K Pcs)
    Table 82. Asia Bifidobacterium Longum Sales by Type (2025-2030) & (K Pcs)
    Table 83. Asia Bifidobacterium Longum Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Bifidobacterium Longum Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Bifidobacterium Longum Sales by Application (2019-2024) & (K Pcs)
    Table 86. Asia Bifidobacterium Longum Sales by Application (2025-2030) & (K Pcs)
    Table 87. Asia Bifidobacterium Longum Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Bifidobacterium Longum Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Bifidobacterium Longum Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Bifidobacterium Longum Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Bifidobacterium Longum Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Bifidobacterium Longum Sales by Region (2019-2024) & (K Pcs)
    Table 93. Asia Bifidobacterium Longum Sales by Region (2025-2030) & (K Pcs)
    Table 94. Middle East, Africa and Latin America Bifidobacterium Longum Sales by Type (2019-2024) & (K Pcs)
    Table 95. Middle East, Africa and Latin America Bifidobacterium Longum Sales by Type (2025-2030) & (K Pcs)
    Table 96. Middle East, Africa and Latin America Bifidobacterium Longum Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Bifidobacterium Longum Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Bifidobacterium Longum Sales by Application (2019-2024) & (K Pcs)
    Table 99. Middle East, Africa and Latin America Bifidobacterium Longum Sales by Application (2025-2030) & (K Pcs)
    Table 100. Middle East, Africa and Latin America Bifidobacterium Longum Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Bifidobacterium Longum Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Bifidobacterium Longum Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Bifidobacterium Longum Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Bifidobacterium Longum Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Bifidobacterium Longum Sales by Country (2019-2024) & (K Pcs)
    Table 106. Middle East, Africa and Latin America Bifidobacterium Longum Sales by Country (2025-2030) & (K Pcs)
    Table 107. ATCC Inc Company Information
    Table 108. ATCC Inc Description and Major Businesses
    Table 109. ATCC Inc Bifidobacterium Longum Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 110. ATCC Inc Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. ATCC Inc Recent Developments
    Table 112. BioGaia AB Company Information
    Table 113. BioGaia AB Description and Major Businesses
    Table 114. BioGaia AB Bifidobacterium Longum Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 115. BioGaia AB Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. BioGaia AB Recent Developments
    Table 117. Mystic Pharmaceuticals Inc Company Information
    Table 118. Mystic Pharmaceuticals Inc Description and Major Businesses
    Table 119. Mystic Pharmaceuticals Inc Bifidobacterium Longum Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 120. Mystic Pharmaceuticals Inc Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Mystic Pharmaceuticals Inc Recent Developments
    Table 122. Hanson Ltd Company Information
    Table 123. Hanson Ltd Description and Major Businesses
    Table 124. Hanson Ltd Bifidobacterium Longum Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 125. Hanson Ltd Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Hanson Ltd Recent Developments
    Table 127. Biofodan A/S Company Information
    Table 128. Biofodan A/S Description and Major Businesses
    Table 129. Biofodan A/S Bifidobacterium Longum Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 130. Biofodan A/S Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Biofodan A/S Recent Developments
    Table 132. BioCare Copenhagen ApS Company Information
    Table 133. BioCare Copenhagen ApS Description and Major Businesses
    Table 134. BioCare Copenhagen ApS Bifidobacterium Longum Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 135. BioCare Copenhagen ApS Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. BioCare Copenhagen ApS Recent Developments
    Table 137. Danisco A/S Company Information
    Table 138. Danisco A/S Description and Major Businesses
    Table 139. Danisco A/S Bifidobacterium Longum Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 140. Danisco A/S Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Danisco A/S Recent Developments
    Table 142. Danone SA Company Information
    Table 143. Danone SA Description and Major Businesses
    Table 144. Danone SA Bifidobacterium Longum Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 145. Danone SA Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Danone SA Recent Developments
    Table 147. Deerland Enzymes Inc. Company Information
    Table 148. Deerland Enzymes Inc. Description and Major Businesses
    Table 149. Deerland Enzymes Inc. Bifidobacterium Longum Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 150. Deerland Enzymes Inc. Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Deerland Enzymes Inc. Recent Developments
    Table 152. Key Raw Materials Lists
    Table 153. Raw Materials Key Suppliers Lists
    Table 154. Bifidobacterium Longum Distributors List
    Table 155. Bifidobacterium Longum Customers List
    Table 156. Bifidobacterium Longum Market Trends
    Table 157. Bifidobacterium Longum Market Drivers
    Table 158. Bifidobacterium Longum Market Challenges
    Table 159. Bifidobacterium Longum Market Restraints
    Table 160. Research Programs/Design for This Report
    Table 161. Key Data Information from Secondary Sources
    Table 162. Key Data Information from Primary Sources
List of Figures
    Figure 1. Bifidobacterium Longum Product Picture
    Figure 2. Global Bifidobacterium Longum Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Bifidobacterium Longum Market Share by Type in 2023 & 2030
    Figure 4. 0.2g/Piece Product Picture
    Figure 5. 0.25g/Piece Product Picture
    Figure 6. Global Bifidobacterium Longum Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Bifidobacterium Longum Market Share by Application in 2023 & 2030
    Figure 8. Medicine
    Figure 9. Others
    Figure 10. Bifidobacterium Longum Report Years Considered
    Figure 11. Global Bifidobacterium Longum Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Bifidobacterium Longum Revenue 2019-2030 (US$ Million)
    Figure 13. Global Bifidobacterium Longum Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 14. Global Bifidobacterium Longum Revenue Market Share by Region (2019-2030)
    Figure 15. Global Bifidobacterium Longum Sales 2019-2030 ((K Pcs)
    Figure 16. Global Bifidobacterium Longum Sales Market Share by Region (2019-2030)
    Figure 17. US & Canada Bifidobacterium Longum Sales YoY (2019-2030) & (K Pcs)
    Figure 18. US & Canada Bifidobacterium Longum Revenue YoY (2019-2030) & (US$ Million)
    Figure 19. Europe Bifidobacterium Longum Sales YoY (2019-2030) & (K Pcs)
    Figure 20. Europe Bifidobacterium Longum Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. China Bifidobacterium Longum Sales YoY (2019-2030) & (K Pcs)
    Figure 22. China Bifidobacterium Longum Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. Asia (excluding China) Bifidobacterium Longum Sales YoY (2019-2030) & (K Pcs)
    Figure 24. Asia (excluding China) Bifidobacterium Longum Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Middle East, Africa and Latin America Bifidobacterium Longum Sales YoY (2019-2030) & (K Pcs)
    Figure 26. Middle East, Africa and Latin America Bifidobacterium Longum Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. The Bifidobacterium Longum Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 28. The Top 5 and 10 Largest Manufacturers of Bifidobacterium Longum in the World: Market Share by Bifidobacterium Longum Revenue in 2023
    Figure 29. Global Bifidobacterium Longum Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 30. Global Bifidobacterium Longum Sales Market Share by Type (2019-2030)
    Figure 31. Global Bifidobacterium Longum Revenue Market Share by Type (2019-2030)
    Figure 32. Global Bifidobacterium Longum Sales Market Share by Application (2019-2030)
    Figure 33. Global Bifidobacterium Longum Revenue Market Share by Application (2019-2030)
    Figure 34. US & Canada Bifidobacterium Longum Sales Market Share by Type (2019-2030)
    Figure 35. US & Canada Bifidobacterium Longum Revenue Market Share by Type (2019-2030)
    Figure 36. US & Canada Bifidobacterium Longum Sales Market Share by Application (2019-2030)
    Figure 37. US & Canada Bifidobacterium Longum Revenue Market Share by Application (2019-2030)
    Figure 38. US & Canada Bifidobacterium Longum Revenue Share by Country (2019-2030)
    Figure 39. US & Canada Bifidobacterium Longum Sales Share by Country (2019-2030)
    Figure 40. U.S. Bifidobacterium Longum Revenue (2019-2030) & (US$ Million)
    Figure 41. Canada Bifidobacterium Longum Revenue (2019-2030) & (US$ Million)
    Figure 42. Europe Bifidobacterium Longum Sales Market Share by Type (2019-2030)
    Figure 43. Europe Bifidobacterium Longum Revenue Market Share by Type (2019-2030)
    Figure 44. Europe Bifidobacterium Longum Sales Market Share by Application (2019-2030)
    Figure 45. Europe Bifidobacterium Longum Revenue Market Share by Application (2019-2030)
    Figure 46. Europe Bifidobacterium Longum Revenue Share by Country (2019-2030)
    Figure 47. Europe Bifidobacterium Longum Sales Share by Country (2019-2030)
    Figure 48. Germany Bifidobacterium Longum Revenue (2019-2030) & (US$ Million)
    Figure 49. France Bifidobacterium Longum Revenue (2019-2030) & (US$ Million)
    Figure 50. U.K. Bifidobacterium Longum Revenue (2019-2030) & (US$ Million)
    Figure 51. Italy Bifidobacterium Longum Revenue (2019-2030) & (US$ Million)
    Figure 52. Russia Bifidobacterium Longum Revenue (2019-2030) & (US$ Million)
    Figure 53. China Bifidobacterium Longum Sales Market Share by Type (2019-2030)
    Figure 54. China Bifidobacterium Longum Revenue Market Share by Type (2019-2030)
    Figure 55. China Bifidobacterium Longum Sales Market Share by Application (2019-2030)
    Figure 56. China Bifidobacterium Longum Revenue Market Share by Application (2019-2030)
    Figure 57. Asia Bifidobacterium Longum Sales Market Share by Type (2019-2030)
    Figure 58. Asia Bifidobacterium Longum Revenue Market Share by Type (2019-2030)
    Figure 59. Asia Bifidobacterium Longum Sales Market Share by Application (2019-2030)
    Figure 60. Asia Bifidobacterium Longum Revenue Market Share by Application (2019-2030)
    Figure 61. Asia Bifidobacterium Longum Revenue Share by Region (2019-2030)
    Figure 62. Asia Bifidobacterium Longum Sales Share by Region (2019-2030)
    Figure 63. Japan Bifidobacterium Longum Revenue (2019-2030) & (US$ Million)
    Figure 64. South Korea Bifidobacterium Longum Revenue (2019-2030) & (US$ Million)
    Figure 65. China Taiwan Bifidobacterium Longum Revenue (2019-2030) & (US$ Million)
    Figure 66. Southeast Asia Bifidobacterium Longum Revenue (2019-2030) & (US$ Million)
    Figure 67. India Bifidobacterium Longum Revenue (2019-2030) & (US$ Million)
    Figure 68. Middle East, Africa and Latin America Bifidobacterium Longum Sales Market Share by Type (2019-2030)
    Figure 69. Middle East, Africa and Latin America Bifidobacterium Longum Revenue Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Bifidobacterium Longum Sales Market Share by Application (2019-2030)
    Figure 71. Middle East, Africa and Latin America Bifidobacterium Longum Revenue Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America Bifidobacterium Longum Revenue Share by Country (2019-2030)
    Figure 73. Middle East, Africa and Latin America Bifidobacterium Longum Sales Share by Country (2019-2030)
    Figure 74. Brazil Bifidobacterium Longum Revenue (2019-2030) & (US$ Million)
    Figure 75. Mexico Bifidobacterium Longum Revenue (2019-2030) & (US$ Million)
    Figure 76. Turkey Bifidobacterium Longum Revenue (2019-2030) & (US$ Million)
    Figure 77. Israel Bifidobacterium Longum Revenue (2019-2030) & (US$ Million)
    Figure 78. GCC Countries Bifidobacterium Longum Revenue (2019-2030) & (US$ Million)
    Figure 79. Bifidobacterium Longum Value Chain
    Figure 80. Bifidobacterium Longum Production Process
    Figure 81. Channels of Distribution
    Figure 82. Distributors Profiles
    Figure 83. Bottom-up and Top-down Approaches for This Report
    Figure 84. Data Triangulation
    Figure 85. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

RELATED REPORTS

Global Taurine and Derivatives Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26D19461
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global OTC Hydrotalcite Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18S16538
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Women's Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14W1499
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Yohimbine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Y1251
Thu Sep 11 00:00:00 UTC 2025

Add to Cart